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Partial agonists have emerged as attractive therapeutic molecules. 2-Me-5HT and tryptamine have been defined as partial agonists of
5-HT3 receptors on the basis ofmacroscopicmeasurements. Because several mechanismsmay limitmaximal responses, we took advan-
tage of the high-conductance form of the mouse serotonin type 3A (5-HT3A) receptor to understand their molecular actions. Individual
5-HT-bound receptors activate in long episodes of high open probability, consisting of groups of openings in quick succession. The
activation pattern is similar for 2-Me-5HT only at very low concentrations since profound channel blockade takes place within the
activating concentration range. In contrast, activation episodes are significantly briefer in the presence of tryptamine. Generation of a
full activation scheme reveals that the fully occupied receptor overcomes transitions to closed preopen states (primed states) before
opening. Reduced priming explains the partial agonism of tryptamine. In contrast, 2-Me-5HT is not a genuine partial agonist since
priming is not dramatically affected and its low apparent efficacy ismainly due to channel blockade. The analysis also shows that the first
priming step is the rate-limiting step andpartial agonists require an increasednumber of priming steps for activation.Molecular docking
suggests that interactions are similar for 5-HT and 2-Me-5HT but slightly different for tryptamine. Our study contributes to understand-
ing 5-HT3A receptor activation, extends the novel concept of partial agonism within the Cys-loop family, reveals novel aspects of partial
agonism, and unmasks molecular actions of classically defined partial agonists. Unraveling mechanisms underlying partial responses
has implications in the design of therapeutic compounds.
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Introduction
Cys-loop receptors are ligand-gated ion channels that include
5-HT3, nicotinic (AChR), GABA, and glycine receptors. 5-HT3
receptors are implicated in neurological disorders, are targets of
antiemetic drugs, and are emerging as novel targets for a wide
number of disorders, including schizophrenia, cognitive dys-
function, and pain (Walstab et al., 2010; Thompson, 2013).
Homomeric serotonin type 3A (5-HT3A) receptors are func-
tional. However, single-channel currents from these receptors
cannot be detected due to their very low conductance (Maricq et
al., 1991; Hussy et al., 1994; Mott et al., 2001). Mutations at the
M3-M4 region lead to the high-conductance form of this recep-
tor, which is a valid model for describing activation at the single-
channel level (Kelley et al., 2003; Corradi et al., 2009).
Partial agonists have emerged as attractive therapeutic mole-
cules because they can either act as agonists without producing
overstimulation or decrease endogenous neurotransmitter activ-
ity without yielding the unfavorable effects that result from the
use of antagonists. For ligand-gated ion channels, partial agonists
have been simplistically defined as ligands that elicit submaximal
currents at saturating concentrations. However, characterization
of a genuine partial agonist is complex because other mecha-
nisms, such as channel blockade or desensitization, limit maxi-
mal responses.
A novel interpretation for partial agonism has been recently
proposed for AChRs and glycine receptors together with strong
evidence supporting the theory that gating reaction in these re-
ceptors is not a simple isomerization from resting to open states
(Colquhoun and Lape, 2012). Single-channel kinetic analysis
fromAChRs, glycine, and 5-HT3A receptors revealed an interme-
diate high-affinity preopen state (flipped state) fromwhich open-
ing can occur (Lape et al., 2008; Corradi et al., 2009). Partial
agonists are less effective because of their reduced ability to
change the receptor conformation to this flipped state (Lape et
al., 2008; Colquhoun and Lape, 2012). Thus, the differences be-
tween full and partial agonists lie largely in the rates from resting
to flipped state, whereas rates for channel opening and closing are
similar between them. An extension of the flip mechanism in
which individual subunits flip independently, referred to as
priming, has well described activation of mutant AChRs (Mukh-
tasimova et al., 2009) and mutant glycine receptors (Lape et al.,
2012). Thus, single-channel kinetic analysis from receptors acti-
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vated by partial agonists or in the presence
ofmutations has allowed the resolution of
novel states that have added in-depth in-
sight into the concept of partial agonism.
In this scenario, we studied activation by
two drugs thought to be 5-HT3 partial
agonists (Hussy et al., 1994; Bower et al.,
2008). Our results demonstrate that
2-Me-5HT is an efficacious agonist but its
maximal response is mainly limited by
channel blockade. In contrast, tryptamine
is a genuine partial agonist: its low efficacy
is due to slow transitions from the fully
liganded closed state to primed states. The
kinetic analysis suggests that priming of
the first subunit is the rate-limiting step
for activation. Our study reveals the bases
underlying partial agonism in a unex-
plored member of this receptor family,
thus extending the next-generation acti-
vation model within the family, and pro-
vides novel information on the activation
mechanism.
Materials andMethods
Expression of high-conductance 5-HT3A recep-
tors. The high-conductance forms of the
5-HT3A receptor of mouse of either sex or 7–5HT3A chimera were
obtained by mutating three arginine residues responsible for the low
conductance to glutamine, aspartic, and alanine as described previously
(Kelley et al., 2003; Bouzat et al., 2004; Corradi et al., 2009, 2011). All
experiments were performed with the high-conductance form of the
receptors. BOSC 23 cells, which are modified HEK 293 cells (Pear et al.,
1997), were transfected with the subunit cDNA and a plasmid encoding
green fluorescent protein to allow identification of transfected cells.
Patch-clamp recordings. Single-channel currents were recorded in the
cell-attached configuration at 20°C. The bath and pipette solutions con-
tained 142 mM KCl, 5.4 mMNaCl, 0.2 mM CaCl2, and 10 mMHEPES, pH
7.4, thus leading the membrane potential to be close to 0 mV. Agonists
were added to the pipette solution. Single-channel currents were re-
corded and low-pass filtered to 10 kHz using an Axopatch 200 B patch-
clamp amplifier (Molecular Devices), digitized at 5s intervals, analyzed
manually, and detected by the half-amplitude threshold criterion using
the TAC 4.0.10 program (Bruxton). Under these conditions, the inward
conductance of the mouse high-conductance 5-HT3A receptor is 67 pS
(Corradi et al., 2009).
Open-time and closed-time histograms were plotted, using a logarith-
mic abscissa and a square-root ordinate (Sigworth and Sine, 1987), and
fitted to the sum of exponential functions by maximum likelihood using
the program TACFit 4.0.10 (Bruxton) with the dead time set at 30 s.
Bursts and clusters of channel openings were identified as a series of
closely separated openings (5) preceded and followed by closings lon-
ger than a critical duration. For defining bursts, the critical time was
taken as the point of intersection of the second and the third component
in the closed time histogram for bursts (c
b). For defining clusters, the
critical duration (c
c) was taken as the point of intersection between the
third closed component and the succeeding one, for 5-HT and tryptam-
ine; or the fourth closed component and the succeeding one for 2-Me-
5HT. Open probability within clusters (Popen) was determined by
calculating the mean fraction of time that the channel is open within a
cluster.
Macroscopic currents were recorded in the whole-cell configuration.
The pipette solution contained 134 mM KCl, 5 mM EGTA, 1 mM MgCl2,
and 10 mM HEPES, pH 7.3. The extracellular solution (ECS) contained
150 mM NaCl, 0.5 mM CaCl2, and 10 mM HEPES, pH 7.4. For dose–
response curves, 2 s pulses of ECS containing different concentrations of
agonist were applied. The solution exchange time was estimated by the
open pipette and varied between 0.1 and 1 ms. Macroscopic currents
were filtered at 5 kHz, digitized at 20 kHz, and analyzed using IgorPro
software (WaveMetrics). Each current represents the average from three
to five individual traces, which were obtained from the same cell and
were aligned with each other at the point where they reached 50% of
maximum. Currents were fitted by the following exponential function
(Eq. 1): I(t)  I0 [exp(t/d]  I, where I0 and I are peak and the
steady-state current values, respectively, and d is the decay time con-
stant. EC50 values from experimental or simulated data were obtained by
fitting dose–response curves with the Hill equation as described previ-
ously (Corradi et al., 2009).
Single-channel kinetic analysis. For kinetic modeling, clusters were se-
lected on the basis of their distribution of mean open duration and open
probability (Corradi et al., 2009). Clusters showing open time and open
probability values within two SDs of the mean of the major component
were selected (80% of the total). The resulting open and closed inter-
vals, from single patches at different ligand concentrations, were ana-
lyzed according to a kinetic scheme using the QuB software (Qin et al.,
1996; QuB suite, www.qub.buffalo.edu, State University of New York,
Buffalo) as described previously (Corradi et al., 2009). The dead timewas
25–30 s. The model and the estimated rates were accepted if the result-
ing probability density functions correctly fitted the experimental open-
duration and closed-duration histograms.
Estimation of rate constants from macroscopic currents was per-
formed with QuB software by fitting the experimental currents on the
basis of a given scheme. Agonist association and dissociation rate con-
stants were estimated by using the macroscopic rate optimizer (MAC)
algorithm included in theQuBpackage (Milescu et al., 2005). Simulation
of single-channel and macroscopic currents were performed using QuB
software based on the model proposed and using the rate constants for
desensitization and recovery experimentally determined.
Statistical comparisons were performed with the Student’s t test.
Molecular docking. A homology model for the extracellular region of
the 5-HT3A receptor was created based on the structure of the
acetylcholine-binding protein engineered to recognize serotonin (Kes-
ters et al., 2013; 5HTBP-AChBP; Protein Data Bank code: 2YMD). The
amino acid sequence for the mouse 5HT3A subunit (accession number:
Q6JIJ7) was aligned with the sequence of the 5HTBP-AChBP using Clust-
alW and the homology modeling was performed using MODELLER 9v8
a b
Figure 1. Macroscopic responses of 5-HT3A receptors by different agonists. a, Macroscopic currents recorded in the whole-cell
configuration elicited by the three agonists at the indicated concentrations (in micromoles per liter). Membrane potential, 50
mV. For 2-Me-5HT and tryptamine (black traces), currents were compared with those elicited by 10M 5-HT (gray trace) in the
same cell. Solid lines represent the 2 s pulse for each ligandwith the agonist concentration inmicromoles.b, Dose–response curves
for 5-HT3A receptors. All current amplitudeswerenormalized to thoseof 10M5-HT-elicited currents and curveswere fittedby the
Hill equation. Data points are the means of3 cells and bars indicate SD.
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(Sali and Blundell, 1993). Ten models were generated. Of these, the one
with the lowest energy and the smallest percentage of amino acids in the
disallowed region of the Ramachandran plot was selected for docking
studies. The protonated form of each agonist was docked into the bind-
ing site region between subunits E and A using AUTODOCK 4.2 (Good-
sell et al., 1996). A hundred genetic algorithm runs were performed for
each docking study.
Results
2-Me-5HT and tryptamine elicit submaximal
macroscopic responses
To evaluate the overall behavior of two serotonin receptor li-
gands, 2-Me-5HT and tryptamine, we recorded macroscopic
currents in the whole-cell configuration from cells expressing
a b
Figure 2. Single-channel currents evoked by low agonist concentrations.a, Single-channel traces obtained in the cell-attached configuration at70mVmembrane potential. For each agonist,
the lowest concentration that evoked single-channel events is shown. Channel activity appears as long groups of openings separated by brief closings (bursts or clusters). The open probability for
the activation episodes is indicated as themean SD (n 3 cells for each agonist). b, Representative open-duration, closed-duration, and cluster-duration histograms obtained from the analysis
of the whole recording.
Table 1. Open and closed durations of 5-HT3A receptor channels in the presence of different ligands
Agonist Concentration
OB
(area)
OI
(area)
OL
(area)
CB
(area)
CI
(area)
CL
(area)
CXL
(area) n
5-HT
0.1M 0.19 0.09 ms 1.0 0.4 ms 106 50 ms 0.05 0.02 ms 0.37 0.20 ms 2.6 0.6 ms — 5
(0.50 0.19) (0.13 0.08) (0.37 0.20) (0.54 0.20) (0.19 0.06) (0.08 0.05)
1M 0.14 0.05 ms 2.4 1.7 ms 113 20 ms 0.04 0.02 ms 0.30 0.11 ms 2.7 0.9 ms — 8
(0.49 0.11) (0.13 0.06) (0.38 0.10) (0.54 0.13) (0.26 0.12) (0.11 0.04)
50M 0.18 0.04 ms 3.6 1.2 ms 11 1 ms 0.02 0.01 ms 0.13 0.01 ms 3.3 0.9 ms — 3
(0.13 0.04) (0.29 0.12) (0.58 0.11) (0.80 0.03) (0.10 0.04) (0.04 0.01)
500M 0.40 0.09 ms — 1.5 0.3 ms 0.03 0.01 ms 0.14 0.08 ms 1.8 1.1 ms — 3
(0.12 0.03) (0.77 0.03) (0.79 0.10) (0.14 0.10) (0.03 0.02)
2-Me-5HT
1M 0.10 0.04 ms 0.84 0.22 ms 20 4 ms 0.05 0.01 ms 0.20 0.08 ms 2.2 0.9 ms 16 8 ms 5
(0.28 0.08) (0.14 0.04) (0.59 0.11) (0.70 0.13) (0.17 0.10) (0.08 0.04) (0.02 0.01)
15M 0.08 0.01 ms — 4.2 1.2 ms 0.05 0.01 ms 0.26 0.09 ms 1.6 0.4 ms 16 7 ms 5
(0.27 0.04) (0.73 0.04) (0.80 0.03) (0.08 0.03) (0.09 0.02) (0.02 0.01)
50M 0.06 0.01 ms — 1.3 0.3 ms 0.05 0.01 ms 0.36 0.21 ms 1.5 0.4 ms 26 10 ms 3
(0.25 0.05) (0.75 0.05) (0.88 0.03) (0.08 0.03) (0.03 0.02) (0.02 0.01)
100M 0.07 0.04 ms — 0.93 0.10 ms 0.04 0.01 ms 0.26 0.15 ms 0.96 0.30 ms 9 4 ms 4
(0.40 0.08) (0.60 0.08) (0.82 0.07) (0.09 0.05) (0.06 0.03) (0.02 0.01)
Tryptamine
10M 0.15 0.06 ms 1.3 0.6 ms 31 13 ms 0.04 0.01 ms 0.22 0.06 ms 2.4 1.4 ms — 9
(0.36 0.16) (0.14 0.04) (0.51 0.23) (0.65 0.15) (0.25 0.15) (0.07 0.05)
50M 0.16 0.03 ms 2.2 1.2 ms 24 4 ms 0.03 0.01 ms 0.17 0.08 ms 1.5 0.9 ms — 5
(0.24 0.10) (0.15 0.03) (0.48 0.16) (0.78 0.04) (0.17 0.04) (0.03 0.01)
100M 0.15 0.04 ms 1.5 0.6 ms 8 2 ms 0.06 0.04 ms 0.31 0.11 ms 2.0 0.9 ms — 5
(0.37 0.21) (0.15 0.05) (0.51 0.15) (0.70 0.18) (0.22 0.15) (0.04 0.03)
500M 0.20 0.06 ms — 1.2 0.2 ms 0.04 0.01 ms 0.16 0.04 ms 1.0 0.3 ms — 4
(0.19 0.10) (0.86 0.13) (0.83 0.15) (0.15 0.12) (0.05 0.02)
Single-channel recordings of the high-conductance form of 5-HT3A receptor in the presence of different concentrations of each agonist.
Clusters were identified as successive openings separated by closings briefer than a critical duration (seeMaterials andMethods). Open-time histograms, constructedwith openings of thewhole recording, were fitted by three components
(OB , OI , and OL ) at low agonist concentrations and by two components at higher concentrations due to open channel blockade. Closed-time histograms from thewhole recording show5–6 closed components but the table shows the three
briefest components (CB , CI , and CL ) that correspond to closings within clusters. CXL corresponds to the new closed component detected in the presence of 2-Me-5HT.
Results are shown as the mean duration SD and n corresponds to the number of patches for each condition.
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5-HT3A receptors. Application of the full
agonist, 5-HT, elicits currents whose de-
cays are well fitted by a single exponential
component (Eq. 1; Fig. 1a). Expressing
the relative peak current as a function of
5-HT concentration results in EC50 values
of 0.94  0.09 M and Hill coefficient
(nH) of 2.7  0.7 (Fig. 1b). Macroscopic
currents elicited by 1–100 M 2-Me-5HT
or 1–1000 M tryptamine show slower
onset compared with those elicited by
5-HT. The rise time, measured from the
t20–80% at saturating concentrations, is
18 8ms for 10M5-HT, 60 20ms for
100M 2-Me-5HT, and 50 7ms for 100
M tryptamine.
When compared with 5-HT, dose–re-
sponse curves for 2-Me-5HT and
tryptamine show higher EC50 values
[5.2 0.6 M (nH, 2.2 0.7) and 40 3
M (nH, 2.0  0.3), respectively] and
smaller maximal responses (0.60  0.03
and 0.22  0.01, respectively), in good
agreement with data previously reported
(Hussy et al., 1994; van Hooft and Vijver-
berg, 1996; Hu et al., 2003; Bower et al.,
2008). Together, these results confirm
that 2-Me-5HT and tryptamine are ap-
parent partial agonists of the high-
conductance 5-HT3A receptor.
Single-channel activity in the presence
of 2-Me-5HT and tryptamine
To determine the molecular mechanism
underlying partial responses, we explored
activation at the single-channel level.
At all 5-HT concentrations (0.1 M)
single-channel activity from cell-attached
patches is readily detected (Corradi et al.,
2009, 2011). Opening events of 4.7 pA
(70 mV) appear in quick succession
grouped in bursts of high open probabil-
ity, which coalesce into long clusters of2 s (Corradi et al., 2009).
Each cluster corresponds to an activation episode of a single re-
ceptor molecule. Open-time histograms from the analysis of the
entire recording show three components whose durations are
200 s, 2.5 ms, and 110 ms (Fig. 2b; Table 1). The three
classes of openings occur within clusters since open-time histo-
grams constructed with only selected clusters also show three
components. Themean duration of the longest open component
clearly decreases at concentrations 3 M due to 5-HT open-
channel blockade (Corradi et al., 2009). At 500 M of 5-HT,
open-time histograms are fitted by only two components as a
consequence of significant channel block (Table 1).
At all 5-HT concentrations, closed-time histograms are fitted
by 5–6 components, where the three briefest correspond to clos-
ingswithin clusters (Fig. 2b; Table 1). The open probability (0.99)
is constant at all agonist concentrations below the blocking ones
(Fig. 2a). Thus, the frequency of clusters but not their properties
differs among different 5-HT concentrations (below the ones
producing open-channel blockade; Corradi et al., 2009).
In the presence of 2-Me-5HT or tryptamine, bursts of open-
ings in quick succession separated by brief closings are detected
(Fig. 2a). The lowest agonist concentrations that allow reliable
opening detection are 10-fold and 100-fold higher for 2-Me-
5HT (1 M) and tryptamine (10 M), respectively, than for
5-HT (0.1 M).
At 1 M 2-Me-5HT, open-time histograms are fitted by three
components whose durations are100 s,1 ms, and20 ms
(Table 1). The duration of the slowest component shows a clear
decrease as a function of drug concentration (Fig. 3a). At concen-
trations 5 M, open-time histograms are fitted by only two
components as a consequence of channel block (Fig. 3a; Table 1).
Closed-time histograms are fitted by 5–6 components at all con-
centrations. The four briefest components correspond to closings
within clusters and theirmean durations are constant at all 2-Me-
5HT concentrations. An increase in the area of the briefest closed
component with the increase in 2-Me-5HT concentration is ob-
served (Table 1). The decrease of the open time and increase in the
proportion of brief closings suggest open-channel block (Neher and
Steinbach, 1978).
At all 2-Me-5HT concentrations, channel activity appears as
long clusters of high Popen composed of 2–3 bursts, similar to
5-HT clusters (Fig. 3a). Cluster duration and Popen decrease as a
a
b
Figure 3. a, b, Single-channel activity in the presence of 2-Me-5HT (a) or tryptamine (b). Left, Representative single-channel
recordings from cell-attached patches at different agonist concentrations. Membrane potential, 70mV. The upper part of each
single-channel recording shows continuous sweeps for each agonist concentration, and the selected portion (dashed lines) is
shown below in a higher time resolution. Right, Representative open-duration, closed-duration, and cluster-duration histograms
obtained from the analysis of the whole recording for each agonist concentration.
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function of agonist concentration for 5-HT and, more pro-
foundly, for 2-Me-5HT (Figs. 3a, 4b).
Thus, it is possible to identify two types of inhibitory effects
associated with the increase in agonist concentration, one
mainly evidenced by the decrease in the duration of opening
events and the other by the decrease in cluster duration.
For tryptamine, single-channel recordings show that despite
its low efficacy (22% in whole-cell recordings) activation also
occurs in bursts of high Popen (0.9; Fig. 3b). However, bursts do
not coalescence into long clusters as in the presence of 5-HT or
2-Me-5HT; they instead appear isolated, thus leading to signifi-
cantly shorter activation episodes (Fig. 3b). Open time histo-
grams of channels recorded at tryptamine concentrations from
10 to 50M show three components of150s,2ms, and30
ms (Table 1; Fig. 3b). At50M tryptamine, a clear reduction in
the duration of the slowest open component is observed (Table
1). Closed-time histograms show 5–6 components, where the
three briefest are constant at all agonist concentrations with du-
rations similar to those observed in the presence of 5-HT or
2-Me-5HT (Table 1).
At 10M tryptamine, themean burst (crit
b ,0.4–1.5ms) and
cluster duration (crit
c ,3–15 ms) are 370 190 and 380 190
ms, respectively, thus confirming that the main form of activa-
tion elicited by tryptamine is in isolated bursts and not in long
clusters. Increasing 10-fold the critical time for cluster selection
does not change the burst duration, confirming the result. Thus,
for tryptamine, each cluster is composed of only one burst. Inter-
estingly, clusters are composed of the three classes of openings
and closings and show high Popen (0.95 at concentrations	500
M). Mean durations of closed periods within clusters are con-
stant at all tryptamine concentrations, and are similar to those
observed for 5-HT and 2-Me-5HT. There is an increase in the
area of the briefest closed component with the increase of
tryptamine concentration (Table 1). The reduction in the dura-
tion of the slowest open component and the increase in the area
of the briefest closed component suggest open-channel blockade,
though this occurs at a significantly higher concentration range
than for 2-Me-5HT.
Together, the main differences at the single-channel level be-
tween the partial agonists and 5-HT are (1) the profound channel
blockade that takes place within the activating concentration
range for 2-Me-5HT and (2) the presence of isolated bursts in-
stead of long clusters for tryptamine.
Open-channel blockade
Because blockade seems to be significant, especially for 2-Me-
5HT, we analyzed this mechanism in detail. We first evaluated
fast-channel blockade that leads to the reduction of open dura-
tion, which we call B1 block. On the basis of a simple open-
channel block mechanism, the slope of the linear relationship
between the inverse of the mean duration of the slowest open
component and agonist concentration allows estimation of the
forward blocking constant (kB1). The estimated kB1 value is
similar for 5-HT (1.3
 106 M1 s1, r2 0.98) and tryptamine
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Figure4. Channel blockade of 5-HT3A receptors.a, Relationship between the inverse of the longest-duration open component and agonist concentration. Datawere fitted by the linear equation
1/open kB[Ag],where kB is the forward blocking rate constant and is the apparent channel closing rate.b, Cluster duration as a function of agonist concentration. For clarity, error bars
are shown in only one direction. The inset shows the curves at higher resolution for concentrations	20M. c, Open probability for clusters at different 2-Me-5HT concentrations at70mV and
70mV ofmembrane potential. For all plots, each point represents themean SD of3 recordings. The inset shows representative clusters obtained at the two differentmembrane potentials.
d, Cluster duration as a function of 2-Me-5HT concentration at70 mV and70 mV.
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(1.7
 106 M1 s1, r2 0.98), whereas it
is one order of magnitude higher for
2-Me-5HT (1.6 
 107 M1 s1, r2 
0.90), indicating its higher open-channel
blocker potency (Fig. 4a).
Because the area of the briefest closed
component increases with drug concen-
tration in parallel with the decrease of the
duration of the slowest open component,
we associated this closed component with
the fast-blocking process. In this scenario,
the inverse of the mean duration of the
closed component provides an estimation
of the unblocking rate constant (kB1,
20,000 s1). Thus, the estimated block-
ing constants, KB1 (kB1/kB1), are 17, 1,
and 15 mM for 5-HT, 2-Me-5HT, and
tryptamine, respectively. This result dem-
onstrates that 2-Me-5HT, as an open-
channel blocker, is15-fold more potent
than 5-HT and tryptamine. Single-
channel amplitudes remain constant at
the range of agonist concentrations as-
sayed. Only at the highest tested concen-
tration of each agonist is there a slight
(8–10%) and statistically significant re-
duction of channel amplitude (4.2  0.1
pA at 500M5-HT, p	 0.05; 3.4 0.7 pA
at 100M 2-Me-5HT, p	 0.05; and 4.0
0.3 pA at 500 M tryptamine, p 	 0.05),
indicating that the majority of channel
blockages are resolved at the concentra-
tions used for the kinetic analysis.
In addition to the reduction in open
duration, cluster duration also decreases
as a function of concentration for 5-HT
and 2-Me-5HT (Fig. 4b). At the concen-
tration corresponding to the EC50 value
for each agonist, cluster duration is not
affected for 5-HT and tryptamine, whereas
it is reduced by 40% for 2-Me-5HT (Fig.
4b). Because the reduction in the mean
open time is due to open-channel block-
ade, an increase in cluster duration as a
function of blocker concentration would
be expected (Neher and Steinbach, 1978).
Therefore, the decrease of cluster dura-
tion could be explained by two possible
mechanisms: (1) a mechanism in which
the blocked receptor closes or desensitizes
(see Fig. 6, Scheme 1), as reported previously for the AChR (Mur-
rell et al., 1991; Dilger et al., 1997); and (2) a mechanism that
involves an additional, long-lived, blocked state (B2) occurring
from the open state through a concentration-dependent transi-
tion (see Fig. 6, Scheme 2).
To further explore the inhibitory actions of 2-Me-5HT, we
recorded channels at70mV (membrane potential) at a range of
drug concentration (Fig. 4c,d). At this positive membrane poten-
tial, open probability and cluster duration show no significant
changes with the increase of drug concentration, in contrast to
the observations at70mV. Thus, the inhibitory effect of 2-Me-
5HT is voltage dependent as expected for channel blockers (Ber-
trand et al., 1990). Moreover, macroscopic current recordings
show that themaximal peak current elicited by 2-Me-5HT is 40%
lower than that elicited by 5-HT at50mVmembrane potential
(p	 0.05, n 7; Fig. 1), whereas it is similar to that of 5-HT at
50 mV (p  0.1, n  7), thus confirming the voltage depen-
dence of 2-Me-5HT inhibition.
Finally, to confirm that 2-Me-5HT and tryptamine act as
blockers of the 5-HT3 pore, we evaluated their effect on the 7–
5HT3A chimeric receptor, which contains the extracellular do-
main of 7 AChR and the transmembrane and intracellular
region of 5-HT3 (Bouzat et al., 2004; Rayes et al., 2005; Corradi et
al., 2009). Single-channel openings activated by 500 M ACh
show reducedmean open duration as a function of concentration
of the serotoninergic ligands present in the pipette solution. The
a b
c d
e f
Figure 5. Kinetic analysis for 5-HT3A receptors activated by the different agonists. Kinetic analysiswas restricted to clusters, for
5-HT and 2-Me-5HT, or to bursts, for tryptamine. For each transition, the mean value of the rate is shown as s1. On the right of
each scheme (a, c, e), the experimental open-duration and closed-duration histograms at different agonist concentrations with
the theoretical curves superimposed are shown (b, d, f ).
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meanduration of the slowest open component, which is 9.0 2.4
ms (n 7) in the control, is reduced to 4.0 1.3 and 1.20 0.05
ms at 5 and 30 M 2-Me-5HT, and to 5.3 1.0 and 0.3 0.1 ms
at 50 and 500M tryptamine, respectively. On the basis of a linear
blocking scheme, this reduction yields estimated values for kB1
of 2.5 
 107 M1 s1 (r2  0.93) for 2-Me-5HT and 4.9 
 106
M
1 s1 (r2 0.99) for tryptamine, which is in close agreement
with those estimated for 5-HT3A receptors.
Together, the analysis shows that for 2-Me-5HT, the acti-
vation pattern, which consists of long clusters of high Popen, is
similar to that of 5-HT only at the lowest concentration that
allows channel detection or at positive membrane potentials
since the concentration range for channel blockade overlaps
with that for activation. For tryptamine, higher agonist con-
centrations are required for channel detection, indicating that
it is the less potent of the tested agonists. Blockade is not
significantly different to that produced by 5-HT and the main
difference in the activation profile resides in the presence of
isolated bursts that do not coalescence into long clusters as
with 5-HT.
Kinetic modeling for partial agonist activation
To identify a plausible mechanism that could explain why these
two agonists partially activate 5-HT3A receptors, we performed
kinetic analyses using data frommacroscopic and single-channel
recordings.
Primed mechanism
Wehave previously generated amodel for 5-HT3A activation that
includes a flip or preopen state from the receptor with three
occupied binding sites, which is sufficient for maximal activation
(Corradi et al., 2009). In this scheme, the three open states are
connected to two intraburst and one interburst intracluster
closed states. However, this scheme cannot describe 2-Me-5HT
activation since single-channel recordings show four closed com-
ponents within clusters instead of three. On the other hand,
primed models have been applied to partial agonists acting on
AChR and glycine receptors (Mukhtasimova et al., 2009; Lape et
al., 2012). In this scenario, we inferred that the primed model
would be better to describe 5-HT3A activation by partial agonists.
As a first approachwe fittedmacroscopic currents, obtained at
different agonist concentrations, using the MAC algorithm from
theQuBSuite (seeMaterials andMethods) to obtain information
about binding and priming steps. Supported by the lack of con-
centration dependence, we assumed that activation mostly
occurs when the receptor has reached the most favorable occu-
pation state (A3R), and therefore we did not consider openings
from double-liganded and monoliganded states (Corradi et al.,
2009). For this macroscopic analysis, we considered a simplified
model with three agonist binding steps, which are required for
maximal responses (Solt et al., 2007; Corradi et al., 2009) and a
single opening. To account for the high open probability within
bursts for all agonists, fast open–closed transitions are required.
However, such transitions cannot explain the low efficacy ob-
served in macroscopic currents. For this reason, it is required to
include a preopen step that limits the efficacy of channel activa-
tion. The main difference in channel activation elicited by full
and partial agonists resides therefore in the first priming step
(Fig. 5, fromA3R toA3R’). The results show that the affinity of the
agonist for the resting state is not greatly reduced. In particular,
the estimated k2/k1 value is similar for tryptamine and 5-HT (Ta-
ble 2), indicating that the reduced affinity by itself cannot explain
the reduction in EC50 values and maximal responses.
We next fitted clusters obtained from single-channel record-
ings in the presence of 5-HT or 2-Me-5HT to the primed scheme
using theMaximum Interval Likelihood algorithm from theQuB
Suite (see Materials and Methods). Because all agonists produce
fast open-channel blockade, we connected a block state to the
longest-duration open state in each scheme (Fig. 5), and fitted
these schemes to a set of single-channel recordings obtained at
different agonist concentrations. For both agonists, open-time
and closed-time histograms are well described by the theoretical
curves (Fig. 5b,d). Thus, the models describe well open-time and
closed-time histograms, and show similar rates for open–closed
transitions within clusters (Fig. 5a–d; Table 2). The main differ-
ence between both agonists is observed in the transition from the
resting state at the maximal occupation needed for activation
(A3R) to the first primed state (A3R’) (Table 2), which corre-
sponds to closings between bursts and within clusters. As shown
by the estimated equilibrium constants (F’), this transition is
slightly less efficient for 2-Me-5HT than for 5-HT (F’2-Me-5HT,
0.40; F’5-HT,0.50, where F’ ’/’; Table 2). It is important
to remark that the rates for the first priming transition obtained
Table 2. Kinetic parameters for 5-HT3A receptor activated by different agonists
5-HT 2-Me-5HT Tryptamine
3’ s
1 782 67 76 7 2 1
3’ s
1 1,484 233 197 20 1,130 680
3’’ s
1 3,600 680 325 27 789 60
3’’ s
1 5,990 1,435 1,673 150 1,062 114
3’’ s
1 — — 1,224 182
	3’’ s
1 — — 970 154
3’’’ s
1 7,680 1,120 5,211 480 2,383 162
3’’’ s
1 15,500 1,350 9,890 1,025 12,100 1,050

3’ s
1 2,345 370 946 58 —
3’ s
1 13,100 1,200 16,000 804 —

3’’ s
1 6,590 560 4,778 290 5,595 267
3’’ s
1 2,440 213 3,290 217 5,736 266

3’’’ s
1 27,600 2,350 27,000* 27,000*
3’’’ s
1 15 1 83 4 35 2
F’ 0.53 0.09 0.40 0.05 0.002 0.001
F’’ 0.60 0.18 0.20 0.02 0.74 0.10
F’’’ 0.50 0.08 0.53 0.07 0.20 0.02
3’ 0.18 0.03 0.06 0.01 —
3’’ 2.7 0.3 1.3 0.1 0.98 0.06
3’’’ 1,840 200 325 16 770 44
k1 M
1s1 
 10 6 15 9 1.0 0.6 60 30
k2 s
1 150 90 37 17 620 250
k3 s
1 0.27* 0.27* 0.27*
R s1 0.01* 0.01* 0.01*
kB1 M
1s1 
 10 6 1.4 0.1 24 1 2.5 0.1
kB1 s
1 25,100 920 22,400 516 38,400 1,322
d s
1 1.2* 1.2* 1.2*
d s
1 0.01* 0.01* 0.01*
c 400 200 400* 400*
c s
1 	1 	1* 	1*
kB2 M
1s1 
 10 3 118 75 50* 1.8*
kB2 s
1 	1 	1* 	1*
Kinetic parameters corresponding to the activation scheme shown in Figure 7.
For tryptamine, the rates for the first priming (3’) and unpriming (3’) were determined frommacroscopic current
analysis. For 5-HT and 2-Me-5HT, the rates shown in the tablewere determined from cluster analysis. Similar values
were determined frommacroscopic currents (124 33 s1 and 690 130 s1 for 5-HT, and 102 60 s1 and
477285 s1 for 2-Me-5HT, for3’ and3’, respectively). For 5-HT, c, c, kB2, and kB2wereestimated from
the fit of macroscopic currents. For 2-Me-5HT and tryptamine, kB2 was estimated from the decrease of cluster
duration as a function of agonist concentration. k3 , d, and d for 5-HT were constrained to values reported
previously (Corradi et al., 2009). For 2-Me-5HT and tryptamine 
3’’’, k3 , d, d, c, c, and kB2 were con-
strained to values obtained for 5-HT to allow a better fit and good representation of the simulated data. Rates are
expressed asmean SE for at least three different patches. The equilibrium constants are F/ for priming and

/ for gating.
*Constrained rates.
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from the single-channel data are very similar to those obtained
from the macroscopic current analysis (Table 2).
In the presence of tryptamine, activation occurs in isolated
bursts, i.e., each cluster is composed of a single burst. Therefore,
we first fitted single-channel data to the same model as that for
5-HT but lacking the interburst intracluster closed state (A3R-to-
A3R’ transition). This reduced model could not describe open
time distributions because the rates for the first primed-open
transition (A3R’ to O1), and in consequence O1, could not be
solved. Because our single-channel analysis revealed that the
three classes of openings occur within a burst, we next tested
whether open components could be well described by using an
alternativemodel inwhich the first primed-open transition (A3R’
to O1) was excluded but the O1 and O2 states were connected,
allowing the representation of the three open states (Fig. 5e). On
the basis of this model, the theoretical curves superimposed well
on the experimental histograms (Fig. 5f).
A remarkable aspect of the results of our kinetic analysis is that
the first priming step is the one that limits the efficacy of partial
agonists; in other words, once the receptor overcomes this tran-
sition, the second and third priming steps are faster and more
similar to those for 5-HT (Table 2, compare values for F’, F”, F”’).
Another remarkable finding revealed by the analysis is that the
gating equilibrium constant for each open state increases as a
function of the priming step, and three primed subunits are re-
quired for the maximal open-channel stability for all agonists.
The gating equilibrium constants for all open states slightly
differ among agonists (Table 2, compare 3’, 3”, and 3’’’).
The gating equilibrium constant 3”’ is only 2.4-fold lower
for tryptamine than 5-HT. However, the equilibrium constant
for the first priming step (F’) is250-fold lower for tryptam-
ine with respect of that of 5-HT.
Thus, the kinetic analysis from single-channel recordings pro-
vided information about priming, open, closing, and fast-
blocking steps, and that from macroscopic currents about
binding and priming steps. To obtain a complete activation
scheme, we still needed to include the steps underlying the de-
crease in cluster duration.We thereforemodeled the two possible
mechanisms leading to this decrease (Fig. 6, Schemes 1 and 2)
because there is no way of identifying from the experimental data
which of the two takes place.
Scheme 1 incorporates a nonconducting state (CB1) arising
from closing or desensitization of the blocked state (B1), as re-
ported previously for the AChR (Murrell et al., 1991; Dilger et al.,
1997). Although the B1-to-CB1 transition is not dependent on
agonist concentration, CB1 will increase with concentration due
to the concentration dependence of the preceding step, which is
also voltage dependent. Scheme 2 includes an additional, long-
lived, blocked state (B2) connected to the open state through a
concentration-dependent transition.
We have previously determined that the decrease of cluster
duration as a function of 5-HT follows the decrease in the decay
time constant of macroscopic currents obtained from rapidly
perfused outside-out patches (Corradi et al., 2009). Therefore,
for 5-HT, c and c (Fig. 6, Scheme 1) and kB2 and kB2 (Fig. 6,
Scheme 2) were estimated by fitting the decay of macroscopic
currents obtained from outside-out patches at a range of concen-
tration using MAC (QuB software; Table 2). However, currents
elicited by tryptamine and 2-Me-5HT are too small to be mea-
sured from outside-out patches and whole-cell currents do not
allow reliable estimates of the decay time constants. Therefore,
for these agonists, c, c, and kB2 were constrained to those
determined for 5-HT (Table 2), and kB2 was estimated from the
decrease of cluster duration as a function of agonist concentra-
tion (Fig. 4b; Table 2).
Combining the rate constants resulting from macroscopic
and single-channel kinetic analysis leads to the full scheme shown
in Figure 7 with the corresponding rate constants in Table 2.
Based on this kinetic model, both single-channel and macro-
scopic simulations reproduce well the experimental results (Fig.
7b,c). Macroscopic current simulations show the changes in effi-
cacy for channel activation by 2-Me-5HT and tryptamine with
respect to 5-HT (Fig. 7b). Single-channel simulations also resem-
ble the experimental data for the three agonists and show the
reduction in open time and cluster duration due to fast and slow
blockade (Fig. 7c). No differences of the simulated channels and
currents were observed between the two possible mechanisms
underlying cluster duration decrease. The fact that it is not pos-
sible to ascertain which of these two mechanisms leads to slow
blockade does not affect our conclusion that 2-Me-5HT is not a
genuine partial agonist. In fact, at the lowest tested concentra-
tion, at which block is not significant, the simulated data well
reproduce the experimental data for 2-Me-5HT (Fig. 7).
The final scheme revealed the basis underlying partial re-
sponses. 2-Me-5HT is partial mainly because of its potent action
as a channel blocker in addition to its slightly reduced priming. In
contrast, tryptamine behaves as a genuine low-efficacy agonist
and shows significantly reduced priming,which results in the lack
of long activation episodes.
Molecular docking of partial agonists
To visualize how the agonists interact with the binding site, we
performed molecular docking studies using a homology model
for the extracellular domain of 5-HT3 and the protonated forms
of each agonist (Fig. 8). The docking results show 5-HT in two
main possible orientations with similar binding energy but dif-
ferent frequency (Fig. 8, Models 1 and 2). These orientations are
similar to those previously reported (Price et al., 2008; Thompson
et al., 2010), but slightly different to those in the template
5HTBP-AChBP structure, which corresponds to AChBP con-
Figure 6. Kinetic schemes that explain the reduction in cluster duration as a function of agonist concentration. The simplifiedmodels have three binding steps (R to A3R), one primed (A3R’), one
open (O), one desensitized (A3D), and a fast-block state (B1). Scheme1 includes a closed or desensitized state (CB1) connected to B1. Scheme2 includes a second block state (B2). The duration of both
states, CB1 and B2, are longer than the critical time used for cluster selection.
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taining key 5-HT3 residues at the binding
site (Kesters et al., 2013).
Model 1 (Fig. 8) is the most frequently
observed conformation (50%), where
the amino groupof 5-HThas the potential
tomake cation- interactions withW183,
F226, andY234,H-bondswith E129 of the
principal face, and cation- interaction
with W90 of the complementary face.
This model also shows the indol nitrogen
of 5-HT making an H-bond with Y234 in
loop C (principal face). Mutagenesis ex-
periments have demonstrated that these
residues are important for channel func-
tion (Price and Lummis, 2004; Sury-
anarayanan et al., 2005; Price et al., 2008).
In Model 2 (Fig. 8), the amino group of
5-HT makes cation- interaction only
withW183, and the aromatic ring of 5-HT
is involved in – interaction with W90.
The main difference with Model 1 is that
the hydroxyl group of 5-HT is orientated
toward E129making anH-bond, an inter-
action that has been suggested as critical
for binding and gating (Sullivan et al.,
2006; Price et al., 2008; Miles et al., 2012).
Both models show potential interactions
with residues from loop E (Y141, Y143,
and/or Y153), which could be important
for activation (Beene et al., 2004; Hazai et
al., 2009; Kesters et al., 2013). Docking re-
sults for 2-Me-5HT are similar to those of
5-HT (Fig. 8), suggesting that both ago-
nists have the same capability to interact
with the binding site.
For tryptamine, docking analysis
shows the twomain conformations repre-
sented by Models 1 and 2 with similar
interactions to those of 5-HT and 2-Me-
5HT (Fig. 8). However, because tryptam-
ine lacks the hydroxyl group, H-bonds
with Y141, Y143, Y153, and Y234 (Model
1) or with E129 (Model 2) are missing,
suggesting that they could be important
for determining ligand efficacy, as previ-
ously described (Price et al., 2008).
Discussion
It has been recently shown that partial
agonism in AChR and glycine receptors is
not a property of the open–closed transi-
tion as has been supposed for the last 50
years. Instead, it arises in the earlier con-
formational change from the resting state
to an intermediate preopen conforma-
tional state (Lape et al., 2008; Mukhtasi-
mova et al., 2009). Global fitting of
schemes to single-channel data for AChR
and glycine receptors has allowed the
identification of closed intermediate
states that may represent activation inter-
mediates between the agonist-bound rest-
ing state and the opening of the channel.
a
b
c
Figure 7. Single-channel andmacroscopic current simulations. a, Full activation scheme that explains 5-HT3A receptor activa-
tion by the three agonists. Dashed black arrows represent the kinetic transitions that are mainly affected by the efficacy of the
agonist. The dashed gray arrow between O2 and O3 is shown to suggest the possible transition. The complete scheme includes the
two possible blocking mechanisms leading to cluster reduction (dashed line box for Scheme 1 and solid line box for Scheme 2).
Kinetic constants are shown in Table 2.b, Left,Macroscopic currents simulated on thebasis of the complete scheme shown ina. For
the simulations, we considered 1000 receptors and a single-channel amplitude of 4.6 pA. Right, Simulated dose–response curves.
Each point corresponds to the peak of the simulated current relative to the peak of the current simulated at 10M 5-HT. Simulated
datawere fitted to theHill equation. c, Simulated single-channel currents for eachagonist at the shownconcentration. Simulations
correspond to the complete scheme, including Scheme 2, as themechanismof slowblock. No differences in the simulated currents
were observed when Scheme 1 was used instead.
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The conformational changes leading to
these intermediate states may be con-
certed (flipmodel; Burzomato et al., 2004;
Corradi et al., 2009; Sivilotti, 2010) or not,
which involves individual “priming” of
each binding site (Mukhtasimova et al.,
2009; Lape et al., 2012). These observa-
tions have revised the classical model of
activation of these receptors from a scheme
comprising agonist binding and channel
gating steps, to a new one comprising ago-
nist binding, priming or flipping, and chan-
nel gating (Lape et al., 2008, 2012;Corradi et
al., 2009; Mukhtasimova et al., 2009;
Krashia et al., 2011). The intermediate pre-
open states determine agonist efficacy and
they therefore contribute to synaptic
responses.
We here explore molecular bases un-
derlying partial agonism in a not-yet-
characterized Cys-loop receptor, the
5-HT3A receptor. Our results reveal that,
as in related receptors, reduced priming
explains the partial agonism of tryptam-
ine at 5-HT3A receptors. They also show
that 2-Me-5HT, which has been consid-
ered a typical low-efficacy partial agonist,
is a potent channel blocker. This dis-
tinction has significant implications for
rational drug design since changes in
membrane potential may have great vari-
ations in the efficacy of drugs whose par-
tial responses are due to channel
blockade. Thus, this finding enhances the
importance of single-channel kinetic
studies for all ligand-gated ion channels.
Single-channel characterization of
5-HT3A receptors has lagged behind be-
cause of its low conductance and its
complex kinetics. To overcome the low
conductance, we used the high-
conductance form of this receptor (Kelley
et al., 2003), whose activation properties
are similar to those of the wild type (Corradi et al., 2009). A
unique feature of 5-HT-elicited single-channel activity is that
openings appear in clusters even at the lowest concentration that
allows detectable openings. Clusters, which are composed of
bursts of closely spaced openings, show, independently of agonist
concentration, high Popen and three open states and three or four
closed states (Corradi et al., 2009, 2011). At concentrations below
the blocking ones, the activation pattern by 2-Me-5HT is almost
indistinguishable to that elicited by 5-HT. In contrast,
tryptamine elicits isolated bursts of high Popen that are not
grouped into the typical 1–2 s clusters. However, the high
Popen of bursts cannot explain the dramatic changes observed
at the macroscopic level when compared with 5-HT responses,
represented by20% of maximal response, 40-fold increased
EC50 value, and threefold increased rise time. Results from our
single-channel kinetic analysis revealed explanations for this
apparent controversy.
We previously generated a model for 5-HT3A receptors acti-
vated by 5-HT that describes binding, gating, and desensitization,
and includes a concerted conformational change of the triple-
liganded receptor to an activatable state while the channel is still
shut (Corradi et al., 2009), similar to the flip model first reported
for glycine receptors (Lape et al., 2008). We here applied kinetic
analysis for two classical partial agonists and found that the
flipped model, which contains only one preopen state, cannot
well describe the experimental data. We therefore applied the
primed model, as required before for mutant glycine receptors
(Lape et al., 2012). Kinetic analysis from single-channel record-
ings, which provides information about priming, open, and clos-
ing transitions, was combined with that from macroscopic
current recordings to obtain a complete activation model that
also includes agonist binding and desensitization (Fig. 7; Table
2). The generalmodel shows that after binding threemolecules of
agonist, the receptor overcomes the first priming transition to a
closed preopen state (Fig. 7a, A3R’) fromwhere it can either open
or prime to A3R” and A3R”’ states (Fig. 7a). From each primed
state, the receptor is able to open; and the gating equilibrium
constant increases with priming. Interestingly, tryptamine can-
not lead to channel opening from the first primed state (Fig. 5e),
in close agreement with its low efficacy. This observation suggests
Figure 8. Molecular docking of ligands into the 5-HT3A binding site. The model was obtained by homology modeling of the
structure of the acetylcholine binding protein engineered to recognize serotonin (Kesters et al., 2013; 5HTBP-AChBP; Protein Data
Bank code: 2YMD). The figure shows the two possible orientations for each agonist. The agonist orientation and interactions with
residues in the binding pocket are similar for 5-HT and 2-Me-5HT.
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that partial agonists require an increased number of primed sub-
units to allow activation.
Themain conclusions from our kinetic analysis are as follows:
(1) the low efficacy of tryptamine, and to a lesser extent of 2-Me-
5HT, is due to reduced priming; (2) the first priming step seems
to be the rate-limiting step for gating, and priming seems to be
highly cooperative among subunits (in other words, once a sub-
unit has primed, priming is faster for the rest); (3) the first prim-
ing transition is the one that mostly differs among agonists,
whereas opening and closing transitions are similar among ago-
nists; (4) the gating equilibrium constant increases with priming
(i.e., it is higher in receptorswith three primed subunits thanwith
only one; Table 2, compare 3’, 3”, and 3”’); and (5) the open-
channel duration increases with priming, as shown before for
AChR (Mukhtasimova et al., 2009). For 5-HT3A receptors, the
maximal open duration is achieved after three primed steps for all
agonists.
At low agonist concentration, at which block is minimized,
2-Me-5HThas slightly reduced efficacy comparedwith 5-HTdue
to a threefold decreased affinity and a 0.8-fold reduced priming
equilibrium constant for the first priming transition (F’). This
agrees with the fact that the activation pattern observed at a very
low 2-Me-5HT concentration is almost identical to that of 5-HT.
Thus, block seems to be the main cause leading to reduced re-
sponses of 5-HT3A receptors by 2-Me-5HT. 2-Me-5HT differs
only in a methyl group from 5-HT, which may therefore be an
important substituent regarding open-channel blockade. In ad-
dition to the reduction ofmean open time as a function of agonist
concentration, there is a significant reduction in cluster duration.
This observation indicates a deviation of the classical open-
channel block mechanism (Gurney and Rang, 1984; Dilger and
Liu, 1992; Bouzat and Barrantes, 1993, 1996; Arias et al., 2006;
Corradi et al., 2011), which could be due to closing or desensiti-
zation of the blocked receptor, or to additional slow blockade
(Gurney and Rang, 1984; Amador and Dani, 1991; Murrell et al.,
1991; Dilger and Liu, 1992; Dilger et al., 1997). Since reduction in
open time and cluster duration depends directly or indirectly on
agonist concentration and voltage, we cannot identify which of
the two mechanisms takes place. Moreover, currents and single
channels simulated on the basis of activation schemes including
either mechanism reproduce well the experimental data. There-
fore, the uncertainty about which of them is involved in slow
block does not affect our final conclusion. Although 5-HT also
induces slow blockade (Corradi et al., 2009), it is the potency and
not the blocking mechanism that makes 2-Me-5HT behave as a
partial agonist because it shows overlapped concentration ranges
for blocking and activation.
In contrast, tryptamine does not produce significantly in-
creased block with respect to 5-HT, and it behaves as a genuine
partial agonist. Its reduced efficacy is well explained by a 250-
fold reduced priming equilibrium constant. Once priming has
been achieved, the opening–closing transition is remarkably sim-
ilar to that of full agonists. Reduced priming explains why
tryptamine elicits submaximal responses but at the same time
generates a stable open state interrupted by brief closings.
Our docking study shows that the type and frequency of in-
teractions of 5-HT and 2-Me-5HT at the binding site are similar.
The lack of the hydroxyl group of tryptamine affects its capability
to make H-bond interactions with residues at the binding site.
Particularly E129 (detected in Model 2) has been shown to be
important for ligand binding and channel activation in 5-HT3A
receptors (Price et al., 2008) and the equivalent residue, Y93, has
also been shown to be important in AChR function (Aylwin and
White, 1994).
Overall, our study contributes to the understanding of the
mechanism of activation of 5-HT3A receptors, extends the novel
concept of partial agonism to other Cys-loop receptors, reveals
novel aspects of partial agonism, and provides new information
for understanding the mechanism of activation in the Cys-loop
receptor family. Deciphering the molecular bases underlying
submaximal responses has implications in the future for the de-
sign of partial agonists for therapeutic use (Manning et al., 2011;
Revel et al., 2012).
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